Understanding how specific signaling pathways affect cartilage health and osteoarthritis
Analyzing the role of cAMP and STAT3 signaling in cartilage homeostasis and osteoarthritis development
This study is looking at how certain signals in the body help keep cartilage healthy and how problems with these signals might lead to osteoarthritis, using special mice to learn more about it, which could help find new ways to diagnose and treat the condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-11036325 on NIH RePORTER |
What this research studies
This research investigates the role of cAMP and STAT3 signaling pathways in maintaining healthy cartilage and their involvement in the development of osteoarthritis (OA). By studying a genetic mutant mouse model, the researchers aim to uncover how these pathways contribute to cartilage homeostasis and the progression of OA. The project will involve activating cAMP signaling in cartilage and analyzing the resulting cellular changes to better understand the underlying mechanisms of OA. This knowledge could lead to new strategies for early diagnosis and potential treatments for OA.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of developing osteoarthritis or those already experiencing early symptoms of the condition.
Not a fit: Patients with advanced osteoarthritis or those who do not have cartilage-related issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of disease-modifying therapies for osteoarthritis, improving patient outcomes.
How similar studies have performed: Previous research has shown promising results in understanding the role of signaling pathways in cartilage health, suggesting that this approach could yield valuable insights.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Liu, Zhaoyang — University of Southern California
- Study coordinator: Liu, Zhaoyang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.